中文名：CDKI-73
英文名：CDKI-73
纯度：Moligand™，≥95%
货号：C413829
Cas号：1421693-22-2
存储温度：-20°C储存,充氩
运输条件：超低温运输
产品介绍：
Information
CDKI-73 (LS-007) is a potentCDKinhibitor in vitro with IC50 of 8.17 nM, 3.27 nM, 8.18 nM, and 5.78 nM for CDK1, CDK2, CDK4, and CDK9, respectively. CDKI-73 induces apoptosis in cancer cells. CDKI-73 is an orally bioavailable and highly efficaciousCDK9inhibitor against acute myeloid leukemia.
Targets
CDK2 (Cell-free assay); CDK9 (Cell-free assay); CDK1 (Cell-free assay); CDK4 (Cell-free assay) 3.27 nM; 5.78 nM; 8.17 nM; 8.18 nM
In vitro
CDKI-73 induces cancer cells undergoing apoptosis through transcriptional downregulation of anti-apoptotic proteins Bcl-2, Mcl-1 and XIAP by majorly targeting CDK9. Contrastively, it is relatively low toxic to the bone marrow cells of healthy donors.
In vivo
CDKI-73 is orally bioavailable, highly efficacious against MLL-AML MV4–11 xenografts and downregulates anti-apoptotic proteins by targeting CDK9 in vivo.
Cell Research(from reference)
Cell lines：Leukemia cell lines (MOLM13, MV4-11, THP-1, etc.)
Concentrations：0.05 μM, 0.1 μM, 0.25 μM, 0.5 μM
Incubation Time：1 h, 4 h, 12 h, 24 h, 48 h
查看阿拉丁官网此产品相关对应页面：https://www.aladdin-e.com/zh_cn/C413829.html
关键字： GAIOPWBQKZMUNO-UHFFFAOYSA-N ; MS-26626 ; 3-((5-fluoro-4-(4-methyl-2-(methylamino)thiazol-5-yl)pyrimidin-2-yl)amino)benzenesulfonamide ; A925431
上海阿拉丁生化科技股份有限公司是A股上市公司（（股票代码：688179），专注于科研试剂的研发、生产和销售，已陆续建立多个工厂和研发中心。作为领军企业，阿拉丁始终坚持质量第一，连续13年被评为“最受欢迎试剂品牌”。
阿拉丁目前常备库存试剂产品品种超过7万种，SKU总数超过46万，产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域，是国内少数化学试剂到生物试剂全面发展的国产试剂品牌，产品同步发布在我们国内外电商平台。